FRM
IPXL

Fox Run Management’s Impax Laboratories, Inc. IPXL Stock Holding History

Fox Run Management’s Portfolio IPXL Stock Details IPXL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-19,900
Closed -$331K – 1048
2017
Q4 		$331K Sell
19,900
-30,600
-61% -$561K 0.1% 425
2017
Q3 		$1.02M Buy
50,500
+16,900
+50% +$323K 0.29% 57
2017
Q2 		$541K Buy
+33,600
New +$496K 0.19% 197
2017
Q1 		– Sell
-23,500
Closed -$311K – 839
2016
Q4 		$311K Buy
+23,500
New +$402K 0.16% 277

Other funds holding IPXL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
FI
Fosun International Hong Kong, China $399M AUM 16.11% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
TG
TCW Group Los Angeles, California $13.3B AUM 34.44% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fox Run Management's IPXL Position: Q1 2018 in Review

Fox Run Management sold out of Impax Laboratories, Inc. (IPXL) in Q1 2018, closing a stake of 19,900 shares — an estimated $331K sold.

Fox Run Management first reported a position in IPXL in Q4 2016 and held it in 4 quarters. The position peaked at $1.02M in Q3 2017. 188 funds tracked by Wall St. Rank hold IPXL as of Q1 2018.

  • Fox Run Management reported no remaining Impax Laboratories, Inc. position as of Q1 2018 after selling out during the quarter.
  • Fox Run Management sold 19,900 Impax Laboratories, Inc. shares in Q1 2018, an estimated $331K.
  • Fox Run Management first reported a position in Impax Laboratories, Inc. in Q4 2016 and held it in 4 quarters.
  • Fox Run Management's Impax Laboratories, Inc. position peaked at $1.02M in Q3 2017.
  • 188 funds tracked by Wall St. Rank held Impax Laboratories, Inc. as of Q1 2018.

Based on Fox Run Management's 13F filing for Q1 2018, filed 17 Apr 2018.